课题基金 / 基金详情

Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain

Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
验证阻断 TSP4/Cava2d1 相互作用作为神经性疼痛的新靶点
批准号:
10552492
负责人:
ZHIGANG David LUO
金额:
$9.59万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-05-01 至 2024-04-30

项目摘要

项目成果

ZHIGANG David LUO的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 我们从当前的Hear-Initiative奖(1R01DE029202)中生成了各种各样的数据集和文件类型。 由于许多这些单独数据集可能没有接受传输到和的社区标准 存储在选定的存储库,数据集中管理和共享即使不是不可能,也是非常困难的 可供他人访问、可交叉发现、解释、重复使用和长期保存。为了改善我们的数据 关于管理和分享做法,我们建议如下:(1)计划进行自我评估,以 根据公平评估的指导方针,确定我们的数据在公平性方面的独特差距或不足 服务(FAIRSharing.org);(2)改善数据公平性和开发或增强数据的计划 管理和共享计划与国家卫生研究院的现行政策保持一致;(3)采取步骤实施增强的 数据管理和共享。提案的成功完成将提高我们的数据公平性,数据 管理和共享做法,以确保符合美国国立卫生研究院的数据管理和共享政策。
英文摘要
Abstract We generate a wide variety of datasets and file types from our current HEAL-Initiative award (1R01DE029202). Since a lot of these individual datasets may not have accepted community standards for transmission to and storage at selected repositories, it is very difficult, if not impossible, for data centralized management and sharing access by others, cross-discoverability, interpretation, reuse, and long-term preservation. To improve our data management and sharing practice, we propose the following: (1) plans for conducting a self-assessment to identify gaps or deficiencies in FAIRness unique to our data based on the guidelines from FAIR Evaluation Services (FAIRSharing.org); (2) Plans for improving data FAIRness and developing or enhancing a data management and sharing plan to be in line with current NIH policies; (3) Steps toward implementing enhanced data management and sharing. Successful completion of the proposal will improve our data FAIRness, data management and sharing practice to ensure in line with the NIH Policy for Data Management and Sharing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
  • 批准号:
    10452913
  • 项目类别:
  • 资助金额:
    $7.99万
  • 财政年份:
    2021
  • 负责人:
    ZHIGANG David LUO
  • 依托单位:
Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
  • 批准号:
    10670457
  • 项目类别:
  • 资助金额:
    $9.66万
  • 财政年份:
    2019
  • 负责人:
    ZHIGANG David LUO
  • 依托单位:
Nanoparticle mediated in vivo cell-type specific drug delivery for pain relief
  • 批准号:
    8364809
  • 项目类别:
  • 资助金额:
    $22.18万
  • 财政年份:
    2012
  • 负责人:
    ZHIGANG David LUO
  • 依托单位:
Nanoparticle mediated in vivo cell-type specific drug delivery for pain relief
  • 批准号:
    8501694
  • 项目类别:
  • 资助金额:
    $17.39万
  • 财政年份:
    2012
  • 负责人:
    ZHIGANG David LUO
  • 依托单位:
海外基金